Enliven Therapeutics chief medical officer Helen Louise Collins reports sale of $192,342 in common shares
ELVN•Chief Medical Officer Helen Louise Collins sold 5,000 Enliven Therapeutics common shares for $38.4684 each on October 19, 2026, and exercised options for 5,000 shares at $2.48 each.
1. Share transactions
Following the transactions, Collins directly held 25,000 common shares and 101,268 stock options.
